Pinpointing natural cancer drug’s true origins brings sustainable production a step closer

27 mayo 2015

For decades, scientists have known that ET-743, a compound extracted from a marine invertebrate called a mangrove tunicate, can kill cancer cells. The drug has been approved for use in patients in Europe and is in clinical trials in the U.S. By analyzing the genome of the tunicate along with the microbes that live inside it using advanced sequencing techniques, researchers have been able to isolate the genetic blueprint of the ET-743’s producer–which turns out to be a type of bacteria.